BBA
PHXM

Baker Bros. Advisors’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Baker Bros. Advisors’s Portfolio PHXM Stock Details PHXM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-108,597
Closed -$9.31M – 97
2018
Q3 		$9.31M Sell
108,597
-200,000
-65% -$20.8M 0.06% 53
2018
Q2 		$34.5M Sell
308,597
-410
-0.1% -$77K 0.26% 30
2018
Q1 		$64.9M Hold
309,007
– – 0.55% 24
2017
Q4 		$68M Buy
+309,007
New +$73M 0.59% 19

Other funds holding PHXM

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DG
Delek Group Herzliya, Israel $2.59B AUM 1.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Baker Bros. Advisors's PHXM Position: Q4 2018 in Review

Baker Bros. Advisors sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q4 2018, closing a stake of 108,597 shares — an estimated $9.31M sold.

Baker Bros. Advisors first reported a position in PHXM in Q4 2017 and held it in 4 quarters. The position peaked at $68M in Q4 2017. 5 funds tracked by Wall St. Rank hold PHXM as of Q4 2018.

  • Baker Bros. Advisors reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • Baker Bros. Advisors sold 108,597 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q4 2018, an estimated $9.31M.
  • Baker Bros. Advisors first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q4 2017 and held it in 4 quarters.
  • Baker Bros. Advisors's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $68M in Q4 2017.
  • 5 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q4 2018.

Based on Baker Bros. Advisors's 13F filing for Q4 2018, filed 13 Feb 2019.